A detailed history of Brookstone Capital Management transactions in Insulet Corp stock. As of the latest transaction made, Brookstone Capital Management holds 2,511 shares of PODD stock, worth $835,409. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,511
Previous 2,411 4.15%
Holding current value
$835,409
Previous $744,000 12.23%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 15, 2026

BUY
$305.98 - $336.84 $30,598 - $33,684
100 Added 4.15%
2,511 $835,000
Q3 2025

Oct 15, 2025

BUY
$277.3 - $352.82 $438,965 - $558,514
1,583 Added 191.18%
2,411 $744,000
Q2 2025

Jul 30, 2025

BUY
$238.57 - $327.47 $7,634 - $10,479
32 Added 4.02%
828 $260,000
Q1 2025

Apr 29, 2025

BUY
$237.06 - $288.29 $188,699 - $229,478
796 New
796 $209,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $23.1B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Brookstone Capital Management Portfolio

Follow Brookstone Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookstone Capital Management with notifications on news.